Tuesday, October 21, 2014 8:45:49 PM
Think about it who would buy nuvilex at 1$ per share???
when it comes to the millions upon millions of restricted stock under .04. I still think that's quite suspicious.
No one wants to talk about the incredible amount of money given to the board members.
I don't like Kenneth Waggoner one bit. If you look at his history in the past 10 years he's been living off penny stock comp money of companies that turned out to be shams Read about trussnet, and chinatel.
I still don't know how he became CEO of nuvilex. His only connect to this company is Tim Matula. They both worked at VelaTel. Weird thing about that is before Ken came over there was a big spike in their pps. Hmm
Another thing I don't like is Chardan Capital. Mainly because it's almost as if Tim knows Kerry Propper or someone over there pretty well. They give LIVE deal an atm deal and then a few months later give the same to Nuvilex. Just doesn't seem like NVLX earned it. Another thing I should throw in there is that The group that Kerry runs with has been in the trouble in the past. He himself and his father have been named and convicted in federal cases. Most they had to do was pay back millions of dollars but one of their guys got a few years.
It might not mean much. Who knows just looks ugly for the company. I like my stocks to not have such crap like that around them.
Ken must've thought the same or at least knew us talking about that affected the pps. So you can give me a check mark for that.
You could argue that that's in the past and now there are scientists on the board. Okay yeah but it seems like they're there to make sure things are getting done. From looking at filings Austrianova kinda has a tight grasp around nvlx. If nvlx messes around too much that exclusive rights is gone. Not to mention Austrianova has a 10-20% royalty on everything too. Bovarian Nordic (sp) I think has some royalty percentage too.
I'm also skeptical in the technology. We're calling this successful after 2 phases involving 24 patients. I don't think the FDA would even accept that.
Do I think there's a chance? Yes.
More than 25%? Nah
Even then management created a black hole for revenue
Recent PMCB News
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:38:38 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 02:56:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/15/2023 10:25:52 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 10:06:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2023 09:00:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:02:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:02:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:00:10 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 11/22/2023 09:00:15 PM
- PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc. • Business Wire • 11/15/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 10:25:09 PM
- PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology • Business Wire • 10/31/2023 01:15:00 PM
- PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology • Business Wire • 10/31/2023 01:15:00 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/21/2023 09:04:07 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/18/2023 10:04:06 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 09/15/2023 09:00:03 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/12/2023 01:56:25 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:28 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/04/2023 08:40:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/04/2023 08:01:37 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 07/31/2023 09:18:17 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM